Molecular aspects of anti-cancer drug action /

Molecular aspects of anti-cancer drug action /

42

Bibliografski detalji
Glavni autori:	Neidle, S., Waring, Michael J.
Format:
Izdano:	W. Germany: Verlag Chemie, 1983
Teme:	Molecular biology Drug utilization Cancer

Slični predmeti

Targeted down-regulation of SRSF1 exerts anti-cancer activity in OSCC through impairing lysosomal function and autophagy
od: Yi Qu, i dr.
Izdano: (2023-12-01)

Inhibition of FNDC1 suppresses gastric cancer progression by interfering with Gβγ-VEGFR2 complex formation
od: Yao Lu, i dr.
Izdano: (2023-09-01)

Molecular analysis of antimalarial therapies : from drug development to mode of action
od: Dziekan, Jerzy Michal
Izdano: (2019)

Chemistry and molecular aspects of drug design and action /
od: Rekka, E. A., i dr.
Izdano: (2008)

Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline
od: Sarathy, Jickky Palmae, i dr.
Izdano: (2020)

Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer
od: Jianzhou Liu, i dr.
Izdano: (2024-06-01)

CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway
od: Zhengchen Jiang, i dr.
Izdano: (2024-02-01)

Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges
od: Junxia Liu, i dr.
Izdano: (2023-06-01)

Molecular dynamics simulation of interaction of the anti-cancer drug paclitaxel with the cell membrane: investigation of changes in van der Waals energy and center of mass
od: Maedeh Rahimnejad, i dr.
Izdano: (2019-06-01)

Characteristics and molecular mechanism of drug-tolerant cells in cancer: a review
od: Xian-Wen Liang, i dr.
Izdano: (2023-07-01)

Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?
od: Opeyemi Iwaloye, i dr.
Izdano: (2023-01-01)

Drug delivery by SiC nanotubes as nanocarriers for anti-cancer drugs: investigation of drug encapsulation and system stability using molecular dynamics simulation
od: Atousa Faizi, i dr.
Izdano: (2021-01-01)

Revolutionizing anti-cancer drug discovery against breast cancer and lung cancer by modification of natural genistein: an advanced computational and drug design approach
od: Shopnil Akash, i dr.
Izdano: (2023-09-01)

Molecular biology for ancologists /
od: Yarnold, J. R., i dr.
Izdano: (1996)

Drugs : culture, controls, and everyday life /
od: South, Nigel
Izdano: (1999)

Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer
od: Yuting Tang, i dr.
Izdano: (2023-07-01)

Pore length effect on drug uptake and delivery by Mesoporous Silicas/
od: 549883 Burguete, Pedro, i dr.

Drug dan masyarakat Malaysia /
od: 319525 Gan, Ee Kiang
Izdano: (1991)

In silico evaluation of anti-colorectal cancer inhibitors by Resveratrol derivatives targeting Armadillo repeats domain of APC: molecular docking and molecular dynamics simulation
od: Shopnil Akash, i dr.
Izdano: (2024-04-01)

Cancer Stem Cells as Potential Targets of Phytotoxic Alkaloids: Drug-Likeness Prediction and Molecular Docking Studies
od: Charles Okeke Nnadi, i dr.
Izdano: (2024-03-01)

Integration of Molecular Docking and In Vitro Studies: A Powerful Approach for Drug Discovery in Breast Cancer
od: Claudia Cava, i dr.
Izdano: (2020-10-01)

Editorial: Application of advances in molecular and genetic researches to tackle pancreatic cancer: screening, diagnosis, prognostication and drug response prediction
od: Salih Ibrahem, i dr.
Izdano: (2023-11-01)

MOLECULAR BIOLOGICAL FACTORS IN THE PREDICTION OF PROSTATE CANCER
od: S. V. Vtorushin, i dr.
Izdano: (2017-03-01)

Pore length effect on drug uptake and delivery by mesoporous silicas /
od: 549883 Burguete, Pedro author, i dr.
Izdano: (2012)

Osteopontin and Cancer: Insights into Its Role in Drug Resistance
od: Chengcheng Hao, i dr.
Izdano: (2023-01-01)

Molecular pathology in drug discovery and development /
od: Platero, J. Suso
Izdano: (2009)

Molecular biology in medicinal chemistry /
od: Dingermann, Theodor, i dr.
Izdano: (2004)

Molecular pharmacology : from DNA to drug discovery /
od: Dickenson, John
Izdano: (2013)

Molecular-Targeted Drugs in Rheumatology
od: Eiichi Tanaka
Izdano: (2023-12-01)

Artificial molecular motors in biological applications
od: Fuli Fan, i dr.
Izdano: (2025-01-01)

Potential drug interactions in outpatients
od: Luciane Maria Ribeiro Neto, i dr.
Izdano: (2017-01-01)

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec
od: Jason Hu, i dr.
Izdano: (2022-11-01)

Screening and molecular mechanism research on bile microRNAs associated with chemotherapy efficacy in perihilar cholangiocarcinoma
od: Shijie Fu, i dr.
Izdano: (2024-12-01)

KLHL7 promotes hepatocellular carcinoma progression and molecular therapy resistance by degrading RASA2
od: Lin Chen, i dr.
Izdano: (2023-06-01)

Supplementing a specific synbiotic suppressed the incidence of AOM/DSS-induced colorectal cancer in mice
od: Huixia Wu, i dr.
Izdano: (2023-06-01)

Resveratrol in Cancer Prevention and Treatment: Focusing on Molecular Targets and Mechanism of Action
od: Adriana Borriello
Izdano: (2017-11-01)

Molecular biology /
od: Turner, Phil
Izdano: (2005)

The organic chemistry of drug design and drug action /
od: 385654 Silverman, Richard B.
Izdano: (1992)

Penggunaan drug keperluan : termasuk senarai model drug keperluan yang disemak : laporan kelapan Jawatankuasa Pakar WHO /
od: Zabidah Ismail, i dr.
Izdano: (2001)

Anti-Cancer Drug Screening with Microfluidic Technology
od: Mojdeh Monjezi, i dr.
Izdano: (2021-10-01)